Whole-body magnetic resonance imaging in inflammatory diseases: Where are we now? Results of an International Survey by the European Society of Musculoskeletal Radiology

PurposeTo investigate the current role of WB-MRI for rheumatic inflammatory diseases in clinical practice using a survey addressed to musculoskeletal radiologists.MethodsA composed 61 questions, subdivided three sections, demographics (five questions), application adults and children (28 questions: 7 open 21 multiple choice each subgroup) was distributed via European Society Musculoskeletal Radiology (ESSR) from July 2 December 31, 2018 radiologists working academic, private, public workplaces. Comparisons among different workplaces were performed Chi-squared Kruskal-Wallis test nominal ordinal data, respectively (p < 0.05).ResultsSeventy-two participants out 1779 (4%) members ESSR with 10.4 ± 7.9 years experience imaging, replied at least one question. 30.6% 12.3% respondents 50 examinations per year children, respectively. The most frequent indications myositis chronic recurrent multifocal osteomyelitis (CRMO) latter mostly academic centers = 0.013). Arthrits Subcommitte's protocol applied by half especially private used it 0.025). Contrast medium rarely particularly academics 0.04). Diffusion Weighted Imaging 0.01) although, overall, plays marginal role. Scoring systems used. Ongoing research is limited.ConclusionWB-MRI not routinely diseases. are CRMO.